Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending March 16, 2010. The document serves as a notice of the Company's Annual General Meeting (AGM) scheduled for May 6, 2010, and confirms the submission of the 2009 Annual Report to the UK Listing Authority.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding corporate governance and does not contain financial performance data.
Material Changes
No material financial changes versus prior periods are reported in this filing. The document focuses solely on the administrative notification of the upcoming AGM and the availability of the 2009 Annual Report.
Guidance, Outlook, and Risks
There is no management commentary, financial guidance, or discussion of risks and contingencies in this specific filing. The text notes that the 2009 Annual Report, which would contain such details, has been submitted to the UK Listing Authority and is available for inspection at the Financial Services Authority or on the Company's website.
Investor Verification Checklist
- Verify the date and location of the Annual General Meeting (May 6, 2010, London).
- Confirm the availability of the 2009 Annual Report at the UK Listing Authority or on www.gsk.com.
- Note that this filing contains no financial data; investors must refer to the 2009 Annual Report for performance metrics.